NBY - NovaBay Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $-2259.02. This is a potential upside of $-2260.9 (-120260.64%) from yesterday's end of day stock price of $1.88.

NovaBay Pharmaceuticals's activity chart (see below) currently has 2 price targets and 2 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 79.17% with an average time for these price targets to be met of 264 days.

Most recent stock forecast was given by EDWARD WOO from ASCENDIANT on 11-Nov-2024. First documented stock forecast 05-Jun-2017.

Best performing analysts who are covering NBY - NovaBay Pharmaceuticals:

Scott Henry Edward Woo Jay Cohen Raghuram Selvaraju

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 30-Mar-2020

$2.81

$1.31 (87.33%)

$332.5

1 years 4 months 27 days ago
(11-Nov-2024)

2/3 (66.67%)

$0.46 (19.57%)

443

Buy

$3.8

$3.35 (744.44%)

2 years 7 months 27 days ago
(11-Aug-2023)

1/2 (50%)

$7.02 (252.09%)

183

Buy Since 13-Mar-2019

$1531.25

$1530.09 (131904.31%)

7 years 25 days ago
(13-Mar-2019)

1/1 (100%)

$421.9 (38.03%)

89

Buy Since 05-Jun-2017

$4900

$4898.05 (251182.05%)

$6737.5

8 years 12 days ago
(26-Mar-2018)

2/2 (100%)

$-9472.99 (-65.91%)

341

Show more analysts

Please expand the browser size to see the chart

What is NBY (NovaBay Pharmaceuticals) average time for price targets to be met?

On average it took 264 days on average for the stock forecasts to be realized with a an average price target met ratio 79.17

Which analyst has the current highest performing score on NBY (NovaBay Pharmaceuticals) with a proven track record?

SCOTT HENRY

Which analyst has the current lower performing score on NBY (NovaBay Pharmaceuticals) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on NBY (NovaBay Pharmaceuticals)?

Scott Henry works at ALLIANCE GLOBAL PARTNERS and has 7 price targets and 4 ratings on NBY

Which analyst is the currently most bullish on NBY (NovaBay Pharmaceuticals)?

Scott Henry with highest potential upside - $4898.05

Which analyst is the currently most reserved on NBY (NovaBay Pharmaceuticals)?

Edward Woo with lowest potential downside - $1.31

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?